*《华尔街日报》报道：中国芬太尼前体生产商转向在美国销售非法肽类药物*此前，多家中国肽类药物供应商因芬太尼交易在美国被起诉
*CHINESE FENTANYL PRECURSOR PRODUCERS PIVOT TO SELLING BOOTLEG PEPTIDES IN US: WSJ*SEVERAL CHINESE PEPTIDE VENDORS PREVIOUSLY INDICTED IN US OVER FENTANYL TRADE
*CHINESE FENTANYL PRECURSOR PRODUCERS PIVOT TO SELLING BOOTLEG PEPTIDES IN US: WSJ*SEVERAL CHINESE PEPTIDE VENDORS PREVIOUSLY INDICTED IN US OVER FENTANYL TRADE